<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00442091</url>
  </required_header>
  <id_info>
    <org_study_id>20070010</org_study_id>
    <nct_id>NCT00442091</nct_id>
  </id_info>
  <brief_title>Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema</brief_title>
  <official_title>Dandelion Juice in the Treatment of Dyshidrotic Hand Eczema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dandelion juice has been used in herbal medicine for at least 1000 years. Vesicular hand
      eczema is a rare, but difficult to treat, type of hand eczema. One case report has shown that
      ingestion of dandelion juice could induce a beneficial effect on this type of eczema. The
      purpose of this study is to test whether this effect can be retrieved in other patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dandelion juice has been used in herbal medicine for at least 1000 years. One case report has
      shown a beneficial effect of this herbal remedy on dyshidrotic hand eczema, and the purpose
      of this pilot study is to test whether this effect can be retrieved in other patients.

      The patients are recruited from our out-patient clinic. Only patients with negative patch
      tests to Compositae are offered treatment with dandelion juice for 20-30 days.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in dyshidrotic hand eczema in the study period assessed by HECSI score.</measure>
    <time_frame>3-4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in dyshidrotic eczema in the study period assessed by the patient (Visual Analog Scale).</measure>
    <time_frame>3-4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">4</enrollment>
  <condition>Vesicular Palmoplantar Eczema</condition>
  <condition>Pompholyx</condition>
  <arm_group>
    <arm_group_label>10 ml of dandelion juice twice daily</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dandelion juice</intervention_name>
    <description>10 ml bid for 20-30 days</description>
    <arm_group_label>10 ml of dandelion juice twice daily</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients with dyshidrotic eczema for at least 1 year and negative patch test
             reactions to Compositae (tested within the last 3 years) and normal renal and hepatic
             blood tests.

        Exclusion Criteria:

          -  Treatment with systemic steroids or other immunosuppressive/-modulating drugs,
             including UV therapy, within the last 3 months.

          -  Pregnancy, lactation.

          -  Compositae contact allergy.

          -  Liver or gall bladder disease.

          -  Abnormal renal or hepatic blood tests.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evy Paulsen, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Dermatology, Odense University Hospital, DK-5000 Odense C</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Evy Paulsen, Dr.</last_name>
    <phone>+6541 2705</phone>
    <email>evy.paulsen@regionsyddanmark.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Dermatology, Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>DK-5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Evy Paulsen, Dr.</last_name>
      <phone>+45 6541 2705</phone>
      <email>evy.paulsen@regionsyddanmark.dk</email>
    </contact>
    <contact_backup>
      <last_name>Klaus E Andersen, Professor</last_name>
      <phone>+45 6541 2700</phone>
      <email>klaus.ejner.andersen@regionsyddanmark.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Evy Paulsen, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 28, 2007</study_first_submitted>
  <study_first_submitted_qc>February 28, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2007</study_first_posted>
  <last_update_submitted>September 19, 2017</last_update_submitted>
  <last_update_submitted_qc>September 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Evy Paulsen</investigator_full_name>
    <investigator_title>Consultant dermatologist, Ph.D.</investigator_title>
  </responsible_party>
  <keyword>Dandelion</keyword>
  <keyword>herbal remedy</keyword>
  <keyword>hand eczema</keyword>
  <keyword>Compositae</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eczema</mesh_term>
    <mesh_term>Eczema, Dyshidrotic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

